$8.530
-0.252 (-2.96%)At close
SGML News
SGML Events
Sigma Lithium Resumes Mining Operations as Court Upholds Environmental Licenses
Sigma Lithium resumes its mining-industrial operations winning a benchmark legal decision based on technical merits by a Federal Court of Appeals maintaining the validity of its current environmental licenses and enabling a resumption of its mining-industrial operations. Highlights: Federal Court of Appeals upholds Sigma Lithium's environmental licenses, enabling the full resumption of mining-industrial operations following a benchmark legal decision based on technical merits. Confidence in 330,000 tonnes of annualized lithium oxide concentrate production by year-end 2027 strengthened, with existing mine and processing capacity sufficient to meet guidance. Court recognizes the significant economic importance of Sigma Lithium to the Vale do Jequitinhonha, where the Company supports approximately 19,000 direct and indirect jobs and around 80,000 family members across 12 municipalities. Sigma Lithium continues to drive measurable economic and social development across the Lithium Valley, including substantial GDP growth in the municipalities of Aracuai and Itinga and initiatives supporting entrepreneurship, water access, food security, drought resilience and education.
Sigma Lithium Suspends All Production, Expects 330,000t Lithium Oxide in FY27
Sigma Lithium announces that all of its mining and industrial production was temporarily suspended yesterday, on September 30. "The suspension is a result of an atypical 15-day delay by the Federal Court of Appeals in reviewing the Company's legal defense. Sigma Lithium confirms that it remains focused on advancing its expansion plans, expecting to deliver 330,000t of lithium oxide concentrate in FY 27. However, the Company will postpone by 3 months its 12-month guidance of 240,000t. Sigma Lithium will maintain the commercial and recycling operations that ensure the circularity of 100% of its dry stacked tailings, selling high-purity lithium fines, generating cash flow and expecting to continue to self-fund the Company during the temporary suspension. Following this anomalous 15-day delay by the Federal Court of Appeals, the Company received and acknowledged in the evening of September 29 an electronic notification posted by FEAM, in legal conformity with the environmental process of Minas Gerais. However, the temporary suspension will generate significant negative economic impact across 12 municipalities in the Vale do Jequitinhonha. As a key economic growth engine in the region, Sigma Lithium has contributed to the creation of 19,000 direct and indirect job positions, benefiting approximately 80,000 people across 12 municipalities in one of the most economically underserved regions of the State of Minas Gerais," the company stated.
Dow Jones Drops Nearly 600 Points as Oil Prices Surge Raises Inflation Concerns
The major averages closed broadly lower, with the Dow Jones losing nearly 600 points as a renewed jump in oil prices and escalating Middle East tensions stoked inflation concerns.The rise in oil prices is particularly problematic coming after Friday's stronger-than-expected August jobs report. The U.S. added 162,000 jobs, nearly three times economists' expectations, pushing markets to increase bets that the Federal Reserve could raise rates at its September 16 meeting. The probability of a hike is now around 60%, while the 10-year Treasury yield has climbed to roughly 4.8%.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:An Amazoncargo plane overshot the runway at Miami International Airport this weekend,Qualcommannounced awith AmazonGE AerospaceConsolidated Precision Products for $11.75BBoston Scientificsaid it isits Q3 and FY26 net sales and adjusted earnings per share guidanceNovartisshares fell after its Phase 3 HARBOR study for DM12. WALL STREET CALLS:Intelto Outperform at Northland after "material" turnaround progressPelotonto Underweight at Morgan StanleyAirbnbto Outperform at Raymond JamesBest Buyto Neutral at DA DavidsonSpaceXwith a Buy at Pivotal Research3. AROUND THE WEB:Netflixplans to report box office grosses for six upcoming films, Variety reportsNvidia-backedFirmus signed a multi-year deal with OpenAI to supply computing capacity to two Malaysian data centers, Reuters reportsAhead of Oura's upcoming IPO filing, Robinhoodhas been listed as an underwriter, WSJ saysNovo Nordiskhas halted two trials testing of ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, Bloomberg reportsThe Independent Communications Authority of South Africa, South Africa's telecommunications regulator, plans to investigate prices charged by providers such as Netflixand Meta'sWhatsApp, Bloomberg reports4. MOVERS:Roivant Sciencesgained in New York after announcing its Phase 3 PHocus clinical trialPharvarisincreased in New York after announcing its CHAPTER-3 Phase 3 studyD-Wave Quantumwas higher afterwith the U.S. Department of CommerceSigma Lithiumfell after a preliminary judicial rulingBeam Therapeuticswas lower after announcing updated clinical data from its5. EARNINGS/GUIDANCE:United Natural Foodsand provided guidance for FY27ABMand raised its outlook for FY26, with CEO Scott Salmirs highlighting "record quarterly revenue, robust EPS growth and substantial cash generation"Solaris Energyraised itsGeneral Millsreaffirmed itsGameStop, with EPS higher year-over-yearINDEXES:The Dow fell 628.18, or 1.18%, to 52,786.07, the Nasdaq lost 85.58, or 0.32%, to 26,421.41, and the S&P 500 declined 45.08, or 0.58%, to 7,673.52.
Dow Jones Drops Over 500 Points as Oil Prices Rise Reviving Inflation Concerns
The major averages were broadly lower near noon, with the Dow Jones losing over 500 points as a renewed jump in oil prices and escalating Middle East tensions revive inflation concerns.The rise in oil prices is particularly problematic coming after Friday's stronger-than-expected August jobs report. The U.S. added 162,000 jobs, nearly three times economists' expectations, pushing markets to increase bets that the Federal Reserve could raise rates at its September 16 meeting. The probability of a hike is now around 60%, while the 10-year Treasury yield has climbed to roughly 4.8%.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:An Amazoncargo plane overshot the runway at Miami International Airport this weekend,Qualcommannounced awith AmazonGE AerospaceConsolidated Precision Products for $11.75BBoston Scientificsaid it isits Q3 and FY26 net sales and adjusted earnings per share guidanceNovartisshares fell after its Phase 3 HARBOR study for DM12. WALL STREET CALLS:Intelto Outperform at Northland after "material" turnaround progressPelotonto Underweight at Morgan StanleyAirbnbto Outperform at Raymond JamesBest Buyto Neutral at DA DavidsonSpaceXwith a Buy at Pivotal Research3. AROUND THE WEB:Nvidia-backedFirmus signed a multi-year deal with OpenAI to supply computing capacity to two Malaysian data centers, Reuters reportsAhead of Oura's upcoming IPO filing, Robinhoodhas been listed as an underwriter, WSJ saysNovo Nordiskhas halted two trials testing of ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, Bloomberg reportsAir Cairo is set to purchase 15 AirbusA320 family jets, with the deal expected to be finalized as soon as this week, Bloomberg saysThe Independent Communications Authority of South Africa, South Africa's telecommunications regulator, plans to investigate prices charged by providers such as Netflixand Meta'sWhatsApp, Bloomberg reports4. MOVERS:Roivant Sciencesgains in New York after announcing its Phase 3 PHocus clinical trialPharvarisincreases in New York after announcing its CHAPTER-3 Phase 3 studyD-Wave Quantumhigher afterwith the U.S. Department of CommerceSigma Lithiumfalls after a preliminary judicial rulingBeam Therapeuticslower after announcingfrom its Phase 1/2 trial evaluating BEAM-3025. EARNINGS/GUIDANCE:United Natural Foodsand provided guidance for FY27ABMand raised its outlook for FY26, with CEO Scott Salmirs highlighting "record quarterly revenue, robust EPS growth and substantial cash generation"Solaris Energyfor Q3 and Q4General Millsfor FY27GameStop, with EPS higher year-over-yearINDEXES:Near midday, the Dow was down 562.84, or 1.05%, to 52,851.41, the Nasdaq was down 23.20, or 0.09%, to 26,483.79, and the S&P 500 was down 27.48, or 0.36%, to 7,691.12.
Oil Price Surge Revives Inflation Concerns, S&P 500 Set for Weaker Open
The S&P is pointed toward a weaker open as a renewed jump in oil prices and escalating Middle East tensions revive inflation concerns. Brent crude has climbed to about $99 a barrel, while WTI is above $93, as attacks on energy infrastructure in the region raise concerns about further supply disruptions.The oil move is particularly problematic coming after Friday's stronger-than-expected August jobs report. The U.S. added 162,000 jobs, nearly three times economists' expectations, pushing markets to increase bets that the Federal Reserve could raise rates at its September 16 meeting. The probability of a hike is now around 60%, while the 10-year Treasury yield has climbed to roughly 4.8%.The market's attention now shifts to this week's inflation data, with PPI due Thursday and CPI Friday. Hot inflation readings could reinforce expectations for a September hike and put additional pressure on equities, while cooler-than-expected inflation would give the Fed more room to leave rates unchanged despite the strong labor market.In pre-market trading, S&P 500 futures fell 0.16%, Nasdaq futures rose 0.16% and Dow futures fell 0.66%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Roivant Sciencesup 19% after reporting its PHocus clinical trial evaluating mosliciguat for the treatment of pulmonary hypertension associated with interstitial lung disease met primary and secondary endpointsPharavisup 19% after announcing that the primary endpoint and all secondary efficacy endpoints were met in the CHAPTER-3 study evaluating deucrictibant extended-release tablet for the prevention of hereditary angioedema attacksRigetti Computingup 7% after signing a definitive agreement with the U.S. Department of Commerce for an award of $100M in funding to accelerate superconducting quantum computing R&DHerbalifeup 5% after authorizing the repurchase of up to $250M in sharesLOWER -Novartisdown 12% after reporting that the global Phase 3 HARBOR study evaluating del-desiran in people living with myotonic dystrophy type 1 did not demonstrate statistically significant improvement versus placebo on the primary endpoint of video hand opening timeSigma Lithiumdown 11% after a preliminary judicial ruling suspending its environmental licensesPelotondown 5% after Morgan Stanley downgraded the stock to Underweight with a price target of $4.50, down from $5Boston Scientificdown 1% after saying it is unlikely to meet EPS and sales guidance following a cybersecurity incident that resulted in a global disruption to the company's operations
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.